Suchergebnisse - (Subject:"Adalimumab")

PubPharm (1.069)

1

Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era : A Narrative Review

enthalten in: Advances in therapy | 2024

von Allegretti, J. | Brady, J. | Wicker, A. | +2

2

'Totality of Evidence' Approach in the Development of GP2017, an Approved Adalimumab Biosimilar

enthalten in: Advances in therapy | 2024

von Gaylis, N. | Both, C. | Lemke, L. | +2

3

Additional Data in Expanded Patient Populations and New Indications Support the Practice of Biosimilar-to-Biosimilar Switching

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2024

von Cohen, H. | Bodenmueller, W.

4

Biologics for Hidradenitis suppurativa : evolution of the treatment paradigm

enthalten in: Expert review of clinical immunology | 2024

von Maronese, C. | Moltrasio, C. | Genovese, G. | +1

5

Clinical use of biologics for Crohn's disease in adults : lessons learned from real-world studies

enthalten in: Expert opinion on biological therapy | 2024

von Tursi, A. | Mocci, G. | Del Gaudio, A. | +1

6

Selection strategy of second-line biologic therapies in adult patients with ulcerative colitis following prior biologic treatment failure : Systematic review and meta-analysis

enthalten in: Pharmacological research | 2024

von Zhang, H. | Mu, C. | Gu, Y. | +3

7

Ocular toxoplasmosis following anti-tumour necrosis factor-α therapy combined with oral methotrexate therapy : A case report and review of literature

enthalten in: European journal of ophthalmology | 2024

von Patnaik, G. | Pyare, R. | Kaushik, V. | +1

8

How should we approach management of childhood onset chronic anterior uveitis refractory to adalimumab?

enthalten in: Expert review of clinical immunology | 2024

von Foeldvari, I. | Petrushkin, H.

9

Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs : a systematic literature review and meta-analysis

enthalten in: Arthritis research & therapy | 2024

von Gossec, L. | Humphries, B. | Rutherford, M. | +3

10

Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases

enthalten in: Advances in therapy | 2024

von Kay, J. | Cross, R. | Feldman, S. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[107]